Journal Home
Search for

Volume 16, Issue 3, Pages 150-160 (June 2005)


View previous. 6 of 14 View next.

Police drug crackdowns and hospitalisation rates for illicit-injection-related infections in New York City

Hannah L.F. CooperabCorresponding Author Informationemail address, David Wypijc1email address, Nancy Kriegerd2email address

Received 14 June 2004; accepted 18 March 2005.

Abstract 

Using longitudinal data, this analysis tests the hypothesis that eight police drug crackdowns implemented in 27 New York City police precincts between 1995 and 1999 were associated with subsequent increases in monthly precinct-specific hospitalisation rates for illicit-injection-related abscesses, cellulitis, and endocarditis. Crackdowns are sustained police initiatives designed to reduce the possession and sale of illicit drugs through heightened surveillance and arrests of drug users and street-level dealers. We linked hospitalisation data (48,986 illicit-injection-related abscess or cellulitis cases and 5452 illicit-injection-related endocarditis cases) and arrest and United States Census data to police precincts to calculate hospitalisation and arrest rates. Analyses indicate that drug-related arrest rates climbed 39% in the crackdowns’ first year compared with the previous year. Contrary to our hypothesis, we found evidence of a stasis or decline in hospitalisation rates in the crackdowns’ first year, based on multivariate Poisson regression models that included sensitivity analyses that accounted for the increased incarceration of injectors after each crackdown's onset. We discuss several possible explanations for these findings and conclude that future research is warranted regarding the relationship between police strategies and drug users’ health that incorporates inmate health data and both individual-level and precinct-level data.

Article Outline

Abstract

Methods

Stage 1: identifying the crackdowns’ locations, initiation dates, and intensities

Stage 2: describing precinct sociodemographic characteristics

Stage 3: calculation of hospitalisation rates

Stage 4: hypothesis tests

Stage 5: sensitivity analyses

Results

Discussion

Acknowledgment

References

Copyright

Arrests for drug possession in the United States have more than doubled over the course of the past two decades from 540,800 in 1982 to 1,235,700 in 2002 (Federal Bureau of Investigation, 2003). This increase partially reflects a shift in domestic drug control policy from targeting upper-level dealers and distributors to focusing on street-level dealers and users (Boyum & Kleiman, 1994; Kelling & Moore, 1985; Moore, 1990, Williams, 1990). Research suggests that this shift may imperil drug injectors’ health: a small but growing number of qualitative and cross-sectional quantitative studies have concluded that injectors who are fearful of arrest are more likely to borrow syringes and other injection equipment, inject rapidly and miss their intended vein, and skip cleaning their injection site than are other injectors (Aitken, Moore, Higgs, Kelsall, & Kerger, 2002; Bluthenthal, Kral, Erringer, & Edlin, 1999; Bluthenthal, Lorvick, Kral, Erringer, & Kahn, 1999; Cooper, Moore, Gruskin, & Krieger, in press; Maher & Dixon, 1999). Fear of arrest may also impair the ability of syringe exchange programs to provide sterile syringes and other services that reduce the possible harms of injection drug use (Bluthenthal, Kral, Lorvick, & Watters, 1997; Rich, Strong, Towe, & McKenzie, 1999; Wood et al., 2003).

A recent quantitative study conducted by Wood et al. (2004) extended this line of research into policing and injectors’ health by conceptualising the exposure as a particular police strategy rather than fear of arrest, a formulation that might prove useful both to policy makers deciding which police strategies to implement and to programs supporting injectors’ health (Cooper, Moore, Gruskin, & Krieger, 2004; Cooper et al., in press). Such a formulation is also useful because it shifts attention away from solely individual-level exposures (e.g., “fear of arrest”) to explicitly encompass the role of context, or what Rhodes calls the “risk environment”, in shaping the ability of injectors to reduce the harm of their drug use (Rhodes, 2002). In particular, Wood and colleagues compared patterns of drug use and drug treatment participation in two panels of injectors, one panel interviewed 3 months before and the other interviewed 3 months after the onset of a police drug crackdown in Vancouver, Canada's downtown East Side district (Wood et al., 2004). The drug crackdown focused on street-level drug markets and drug users and stationed an additional 50 police officers in the downtown East Side (Wood et al., 2004). The authors concluded that the crackdown had no impact on drug use frequency or participation in methadone maintenance programs among injectors who resided in the downtown East Side (Wood et al., 2004), a finding that supports Weatherburn and Lind's (2001) research regarding crackdowns and admissions to methadone maintenance treatment in Sydney Australia. The study's sample size precluded evaluating the crackdown's possible impact on HIV risk behaviours (Wood et al., 2004).

The salience of conceptualising the exposure as a particular policing strategy rather than fear of arrest in studies of policing and injectors’ health is highlighted by the link between police drug crackdowns and increased arrests for drug possession. In the United States, drug crackdowns are centrally-organised, rapidly-initiated, sustained police efforts constructed to reduce the possession and sale of illicit drugs through heightened surveillance and arrest of drug users and street-level dealers (Greene, 1996). Crackdown strategies in the United States include covert and overt surveillance, such as monitoring areas of intense drug activity, and “buy and busts” in which an undercover officer poses as a drug user to arrest dealers (Greene, 1996). Indicative of their mode of implementation, in New York City (NYC), the locus of this study, the New York City Police Department (NYPD) organised 8 crackdowns in 27 of NYC's 76 precincts from 1995 to 1999, each lasting for a year or more (Giuliani, 1997; Assistant Chief C. Kammerdener, New York City Police Department, written communication, November 29, 1999 and May 15, 2000). As a part of these initiatives, NYPD added up to 18 squads exclusively targeting drug-related street activity to each of the 8 crackdown areas; each squad contained nine officers (C. Kammerdener, written communication, May 15, 2000). These squads were sometimes supported by hundreds of additional patrol officers (Giuliani, 1997).

To augment knowledge about the impact of drug crackdowns, and hence policing policies, on illicit-drug injectors’ health, this analysis uses longitudinal data to test the hypothesis that the initiation of these eight crackdowns between 1995 and 1999 was associated with an increase in monthly, precinct-specific hospitalisation rates for illicit-injection-related abscesses, cellulitis, and endocarditis within the 27 crackdown precincts as compared with baseline rates in these precincts during the months preceding the crackdowns. Abscesses, cellulitis, and endocarditis have been linked with practices that previous studies have found to be related to injectors’ fear of arrest, including borrowing and re-using syringes, not cleaning one's injection site prior to injecting drugs, and missing an intended vein (Herb, Watters, Case, & Petitti, 1989; Murphy et al., 2001; Vlahov, Sullivan, Astemborski, & Nelson, 1992).

Methods 

return to Article Outline

The analysis consisted of five stages: (1) we identified the location and initiation dates of all crackdowns implemented in NYC during the study period and modelled their intensity; (2) we described the sociodemographic composition of each NYC precinct using United States (US) Census data; (3) we calculated precinct-specific monthly rates of hospitalisations for illicit-injection-related abscesses, cellulitis, and endocarditis using New York State hospitalisation data and US Census data; (4) we tested the hypothesis that the crackdowns were followed by an increase in the precinct-specific hospitalisation rates of the infections of interest; and (5) we augmented our statistical modelling with sensitivity analyses that attempted to account for the incarceration of injectors who developed an illicit-injection-related abscess, cellulitis, or endocarditis infection while living in the community and who would have contributed cases to the case count had they not been incarcerated before they could seek treatment at one of the community-based hospital facilities that were the source of our infection data (as described below).

All analyses were run on SAS 8.2 software. The Harvard School of Public Health Human Subjects Committee and the New York State Statewide Planning and Research Cooperative System (SPARCS) Institutional Review Board approved study protocols.

Stage 1: identifying the crackdowns’ locations, initiation dates, and intensities 

Data regarding the locations and initiation dates of drug crackdowns occurring in NYC between 1995 and 1999 were acquired through NYPD's Narcotics Division and newspaper reports of mayoral press conferences. To determine whether the intensity of the crackdowns changed during their implementation, we investigated arrest patterns in crackdown precincts, before and after the crackdowns’ initiations, using a New York State Division of Criminal Justice Services (NYSDCJS) database. NYSDCJS contains information on the major charge in the arrest (i.e., if an individual is arrested for two or more charges, only the most serious is reported), the month and year in which the arrest was made, and the precinct reporting the arrest (New York Division of Criminal Justice Services, 2000). NYSDCJS data, combined with information on precinct population size, were used to calculate the arrest rate for each precinct each month before and during each crackdown's implementation; the methods used to calculate precinct population size are described in the next section.

Exploratory analyses of these data suggest that arrest rates rose markedly in the months following the crackdowns’ onset. The median monthly precinct-specific arrest rate for drug-related offences climbed 39%, from 201 to 279 arrests per 100,000 precinct residents, comparing the 12 months preceding and following the crackdown's onset. Similarly, the median monthly precinct-specific arrest rate for all offences increased by 17% over the same time period, from 559 per 100,000 residents to 652 per 100,000 residents. As is evident in Fig. 1, arrest rates surged in the first quarter of the crackdown and then were relatively sustained thereafter. Additional analyses indicate that the quarter prior to the crackdowns’ onset saw a gradual ramping up in arrest rates in some crackdown precincts, whereas arrest rates in other crackdown precincts declined during these months, a pattern that suggests that the crackdowns were preceded by some type of preparatory period. Accordingly, we identified four apparent crackdown stages:


1)Baseline: 4–15 months prior to crackdown onset;

2)Preparation: quarter prior to crackdown onset;

3)Initiation: month of crackdown onset;

4)Crackdown quarters: four quarters following crackdown onset.


View full-size image.

Fig. 1. Median precinct-specific drug-related arrest rates and total arrest rates in the four quarters before and after the initiation of eight police drug crackdowns in 27 New York City police precincts.


Stage 2: describing precinct sociodemographic characteristics 

Past research suggested that precinct racial/ethnic, poverty, and age composition and precinct borough might hold salience for the patterning of outcomes across precincts over time (Chen & Kandel, 1995; Fordyce, Shum, Singh, & Forlenza, 1998; Friedman et al., 1999; Haverkos, Turner, Moolchan, & Cadet, 1999; Herb et al., 1989, Marzuk et al., 1997; Raveis & Kandel, 1987). Given this research, we posited that, in addition to precinct crackdown status, covariates should include precinct racial/ethnic composition, age structure, borough, and poverty composition. Precinct racial/ethnic composition was operationalised as a continuous variable describing the percent of residents who were non-Hispanic white; precinct age structure was operationalised as the percent of residents aged ≤17 years, 18–64 years, and ≥65 years. Precinct poverty composition was operationalised as a continuous variable describing the percent of residents subsisting below the federal poverty line; this variable was dichotomised in multivariate analyses to denote whether the precinct qualified as a federal poverty area, or an area in which 20% of the population is living in poverty (U.S. Census Bureau, 1995).

To construct sociodemographic variables regarding each precinct's racial/ethnic and age composition, we used 1990 and 2000 Census block-level data. US Census blocks are the smallest unit of Census geography and are delineated by visible and invisible boundaries such as streets and city lines (U.S. Census Bureau, 2003). To estimate the total number of individuals residing in each precinct during each month of the study period, we first used ArcView 3.2 software to geocode NYC 1990 and 2000 Census blocks to the city's 76 police precincts and then summed population counts across all of the Census blocks comprising each precinct. Where precinct boundaries crossed 1990 or 2000 Census block lines, each block's population was distributed across the resulting block fragments in proportion to the fragments’ surface area. These data were used to calculate each precinct's population size, the percent of precinct residents who were non-Hispanic white, and each precinct's age structure for 1990 and 2000. Assuming linear population change over time, we then interpolated each precinct's racial/ethnic and age composition for each month of the study period using 1990 and 2000 data.

Data concerning precinct poverty status were estimated using census block group data because the Census Bureau does not release poverty data at the block level (U.S. Census Bureau, 2000). Census block groups are clusters of Census blocks containing between 250 and 550 housing units (U.S. Census Bureau, 2003). Census block groups (1990 and 2000) were mapped onto police precincts using the same methods as described for Census blocks and precinct-specific poverty figures interpolated for each month of the study period using 1990 and 2000 data.

Stage 3: calculation of hospitalisation rates 

The outcomes of interest were the monthly precinct-specific hospitalisation rates of illicit-injection-related abscesses, cellulitis, and endocarditis. Hospitalisation rate numerators were the number of hospitalisations for an illicit-injection-related abscess, cellulitis, or endocarditis infection during a particular month in a particular precinct. Rate denominators consisted of the number of adults (aged 18–64 years) residing in that precinct that month. We used a subset of the New York State Statewide Planning and Research Cooperative System (SPARCS) database to estimate rate numerators. The SPARCS database obtained by the project contained diagnostic, procedural, demographic, home residence, and admission date information for all individuals admitted to community-based hospital facilities within NYC for treatment of an abscess, cellulitis, or endocarditis infection, regardless of aetiology, between 1995 and 1999. There were no marked changes in SPARCS data collection methods during the study period (oral communication, Gene Therriault, Executive Secretary, SPARCS Data Protection Review Board, November 1, 2000).

To identify cases of illicit-injection-related infections within this database, we constructed algorithms based on extant research using diagnostic, procedural, and patient age data (Ciccarone et al., 2001, Des Jarlais et al., 1999; DeWitt & Paauw, 1996; Joshi, Caputo, Weitecamp, & Karchner, 1999; Murasko & Bernstein, 1999; Schrager, Friedlan, Feinder, & Kahl, 1991; Stone, Stone, & MacGregor, 1990; Straumann, Stulz, & Jenzer, 1990). Specifically, endocarditis cases were classified as illicit-injection-related if: (1) the patient was between 18 and 64 years old; and (2) either had endocarditis of the tricuspid or pulmonary valve, without prior predisposition to such infections, or had an accompanying illicit-drug-related co-diagnosis or procedure mentioned in their medical record. Cases of abscesses and cellulitis were classified as illicit-injection-related if (1) the patient was a non-diabetic individual between 18 and 64 years old; (2) the infection was not iatrogenic; and (3) either the infection occurred on the patient's extremities, a documented frequent site of illicit-injection-related soft tissue infections (Ciccarone et al., 2001, Stone et al., 1990), or the patient had a drug-related co-diagnosis or procedure mentioned in his/her medical record. Because diagnostic codes for abscesses and cellulitis were identical, we treated them as a single outcome.

To locate each selected case within its home precinct, a professional geocoding firm, verified as having high geocoding accuracy (96%) (Krieger, Waterman, Lemieux, Zierler, & Hogan, 2001), first identified the longitude and latitude of each case's home address and then located the corresponding point within an NYC police precinct. Of the 58,637 cases of illicit-injection-related infection identified using the algorithms described above, 7% (4199) cases could not be geocoded to a NYC precinct. The majority of these 4199 cases could not be geocoded because they either had an incomplete home address or gave a post office box as their home address. The addresses of less than 1% of the non-geocodable cases were listed as “homeless” or “undomiciled”. The geocoded sample included 48,986 cases of illicit-injection-related abscesses and cellulitis and 5452 cases of illicit-injection-related endocarditis.

Hospitalisation rate denominators (i.e., the number of individuals aged 18–64 years residing in each precinct during each month of the study period) were calculated with 1990 and 2000 Census block data, using methods identical to those used to calculate precinct population size described in Stage 2, above.

Stage 4: hypothesis tests 

Exploratory analyses of data for all 76 precincts were conducted to elucidate the distribution of the outcomes and each covariate. These exploratory analyses indicated an unanticipated citywide secular rise in hospitalisation rates for the study outcomes and seasonal variations in abscess and cellulitis hospitalisation rates, suggesting that our models should incorporate year and season as covariates.

To test the study hypothesis, we investigated the relationship of each covariate to each outcome in the 27 precincts that experienced a drug crackdown and modelled outcome rates over time in relation to the specified covariates using Poisson regression methods for longitudinal data, exploring possible interactions. Generalised estimating equation methods were used to control for within-precinct correlations over time (Diggle, Liang, & Zegler, 1994).

Stage 5: sensitivity analyses 

We recognised that throughout the study period a proportion of the individuals harbouring the infections of interest would be incarcerated before they could seek inpatient care at a hospital facility reporting to SPARCS and that this proportion would have increased with the onset of the drug crackdown in each crackdown precinct. While incarcerated, these individuals might receive treatment for these infections that obviated the need for inpatient care in community-based hospitals reporting to SPARCS after their release, a supposition supported by research on the quality of care available within the criminal justice system (Farley et al., 2000, White et al., 2001). Accordingly, we attempted to acquire Riker's Island inmate health data on the relevant infections from the New York City Health and Hospitals Corporation (HHC) for the time period of the crackdowns of interest. Access, however, was permitted only to the paper medical records and not to the computerised files; limited resources precluded this project from undertaking the manual medical record abstraction that would have been required to obtain the relevant data.

Given our inability to access relevant inmate health data, we used NYSDJCS data regarding the incarceration of people arrested in each precinct to conduct a sensitivity analysis assessing the impact of the incarceration of at-risk individuals on our results. Alcohol and drug use monitoring system data for New York County (Manhattan) suggests that approximately seven percent of individuals arrested in 1998 had injected cocaine and ten percent had injected heroin during the course of their lifetime (National Institute of Justice, 1999). Based on these data, we assumed that 15% of incarcerated individuals were recent injectors during the baseline period and 25% were recent injectors after each crackdown was implemented. Among these injectors, we assumed that between five and ten percent had an illicit-injection-related abscess or cellulitis infection requiring inpatient hospital treatment at incarceration and between one and five percent had illicit-injection-related endocarditis requiring inpatient hospital treatment at incarceration. Resulting estimates of these cases were then added to the monthly precinct-specific hospitalisation rate numerators and multivariate regressions conducted regarding the relationship of crackdown stages and hospitalisation rates.

Results 

return to Article Outline

Analyses suggest that sociodemographic characteristics of the 27 crackdown precincts in the first month of the study period (January 1995) differed considerably from those of the 49 precincts that did not undergo a precinct-specific drug crackdown between 1995 and 1999. Crackdown precinct residents tended to be younger, more impoverished, and were less likely to be non-Hispanic white than residents of non-crackdown precincts (Table 1). During this baseline period, median hospitalisation rates for illicit-injection-related abscesses, cellulitis, and endocarditis within crackdown precincts were double or more than double those observed for non-crackdown precincts.

Table 1.

Sociodemographic characteristicsa and hospitalisation rates for illicit-injection-related abscesses, cellulitis, and endocarditis for all New York City police precincts, crackdown precincts, and non-crackdown precincts during January 1995

CharacteristicsAll precincts (N=76)Crackdown precincts (N=27)Non-crackdown precincts (N=49)
Precinct population size (mean, standard deviation)101,000 (48,000)89,000 (40,000)107,000 (51,000)
Precinct age structure (mean, standard deviation)
0–17 years23.1% (7.8)29.0% (5.6)20.0% (6.9)
18–64 years64.7% (6.7)61.5% (4.3)66.7% (7.2)
>65 years12.2% (4.0)9.5% (2.3)13.3% (3.8)
Percent of residents subsisting below the federal poverty line (mean, standard deviation)21.8% (12.3)33.0% (11.3)15.6% (7.7)
Percent non-Hispanic white residents (mean, standard deviation)38.2% (29.1)12.0% (17.3)52.6% (23.7)
Crude monthly hospitalisation rates for illicit-injection-related infections (per 100,000)
Abscess/cellulitis
Mean (standard deviation)22.9 (39.6)24.4 (13.8)22.0 (48.2)
Median (interquartile range)13.4 (9.2–25.7)20.8 (13.2–34.4)11.0 (7.8–20.3)
Endocarditis
Mean (standard deviation)2.4 (2.9)3.6 (2.4)1.7 (2.9)
Median (interquartile range)1.5 (0.0–4.2)3.3 (2.0–5.5)0.0 (0.0–2.0)
a

Precinct sociodemographic profiles for January 1995 were interpolated using 1990 and 2000 US Census block and block group data for New York City assuming linear change over time.

Bivariate analyses suggest that abscess and cellulitis infections followed a seasonal pattern, spiking during summer months (Table 2); endocarditis infections did not follow such a trend. Bivariate analyses also provide evidence of an underlying secular increase in infection rates within crackdown precincts, with abscess and cellulitis hospitalisation rates in 1999 substantially higher than in 1995 and endocarditis hospitalisation rates in 1999 substantially higher than in 1996. Rates of abscess, cellulitis, and endocarditis hospitalisations were approximately 1.8 times higher in precincts in which 20% or more of the population lived at or below the poverty line than elsewhere; the percentage of precinct residents aged 18–64 was inversely associated with hospitalisation rates for all infections studied. The percent of non-Hispanic whites residing in a precinct was inversely associated with endocarditis hospitalisation rates; while hospitalisation rates for abscess and cellulitis infections showed a similar trend, the trend did not reach statistical significance. Abscess, cellulitis, and endocarditis hospitalisation rates varied geographically, with rates higher in the boroughs of Brooklyn and Manhattan than in Queens.

Table 2.

Crude and adjusted regressions of precinct characteristics, season, year, and crackdown stages on precinct-specific hospitalisation rates for illicit-injection-related abscesses, cellulitis, and endocarditis, among NYC's 27 crackdown precincts, 1995–1999

CovariatesHospitalisations for abscesses/cellulitisaHospitalisations for endocarditisa
Crude relative riskb (95% confidence interval)Adjusted relative riskc (95% confidence interval)Adjusted P-valueCrude relative risk (95% confidence interval)Adjusted relative risk (95% confidence interval)Adjusted P-value
Season
Winter0.75 (0.70–0.81)0.76 (0.71–0.82)<0.00010.86 (0.71–1.04)0.84 (0.69–1.02)0.08
Spring0.87 (0.81–0.93)0.87 (0.82–0.91)<0.00010.96 (0.82–1.12)0.94 (0.81–1.10)0.43
Fall0.84 (0.79–0.89)0.86 (0.82–0.93)<0.00011.14 (0.98–1.33)1.18 (1.00–1.39)0.05
Summer (referent)1.001.001.001.00
Percent residents living below poverty level
≥20%1.88 (1.54–2.29)0.67 (0.41–1.09)0.101.83 (1.51–2.23)0.93 (0.50–1.74)0.83
<20% (referent)1.001.001.001.00
Percent residents non-Hispanic white0.99 (0.98–1.00)0.99 (0.98–1.00)0.0020.98 (0.98–0.99)0.99 (0.98–1.00)0.007
Percent residents aged 18–64 years0.94 (0.91–0.97)0.96 (0.95–0.98)0.00020.94 (0.92–0.97)0.98 (0.95–1.01)0.15
Boroughd
Bronx1.64 (1.21–2.22)2.20 (1.29–3.76)0.0041.45 (0.97–2.18)1.42 (0.78–2.58)0.25
Brooklyn2.46 (1.95–3.10)2.82 (1.66–4.81)0.00011.81 (1.50–2.18)1.53 (0.82–2.84)0.18
Manhattan1.53 (1.26–1.85)2.49 (1.46–4.26)0.00081.48 (1.19–1.84)1.86 (0.93–3.72)0.08
Queens (referent)1.001.001.001.00
Year
19950.63 (0.47–0.85)0.57 (0.38–0.84)0.0050.86 (0.63–1.19)0.62 (0.32–1.22)0.17
19960.59 (0.44–0.78)0.60 (0.45–0.82)0.0010.63 (0.46–0.88)0.50 (0.30–0.86)0.01
19970.55 (0.41–0.73)0.60 (0.48–0.74)<0.00010.62 (0.44–0.87)0.60 (0.41–0.90)0.01
19980.74 (0.59–0.93)0.74 (0.63–0.86)0.00010.74 (0.56–0.98)0.68 (0.50–0.93)0.01
1999 (referent)1.001.001.001.00
Crackdown stagese
Baseline (referent)1.001.001.001.00
Preparation0.96 (0.90–1.02)0.94 (0.85–1.04)0.251.11 (0.88–1.40)1.21 (0.96–1.54)0.11
Initiation month0.99 (0.89–1.09)0.89 (0.78–1.00)0.060.92 (0.68–1.26)0.96 (0.66–1.41)0.85
First crackdown quarter1.06 (0.98–1.15)0.88 (0.77–1.00)0.060.92 (0.73–1.16)0.91 (0.66–1.25)0.54
Second crackdown quarter1.09 (0.98–1.22)0.86 (0.74–0.99)0.040.89 (0.73–1.09)0.81 (0.62–1.06)0.13
Third crackdown quarter0.94 (0.87–1.02)0.80 (0.67–0.94)0.0080.87 (0.66–1.15)0.74 (0.53–1.05)0.09
Fourth crackdown quarter0.79 (0.71–1.15)0.72 (0.57–0.91)0.0060.62 (0.44–0.89)0.57 (0.35–0.92)0.02
a

48,986 abscess and cellulitis cases and 5452 endocarditis cases aggregated to the precinct level.

b

“Crude” analyses can also be thought of as bivariate analyses.

c

“Adjusted” analyses included all variables listed in the table as model covariates.

d

No crackdowns occurred in Staten Island during the study period.

e

Crackdown stage definitions: Baseline: 4–15 months prior to crackdown initiation; Preparation: 1–3 months prior to crackdown initiation; Initiation month: month of crackdown initiation; Crackdown quarters: quarters following each crackdown's initiation.

Multivariate analyses based on infections among only the non-institutionalised population indicated that declines occurred in illicit-injection-related abscess, cellulitis, and endocarditis hospitalisation rates following the crackdowns’ onset, especially during the fourth quarter. Sensitivity analysis results (Table 3), however, suggest that hospitalisation rates for illicit-injection-related abscesses and cellulitis either declined only in the fourth crackdown quarter or remained static after the crackdowns’ onset, depending on whether we assumed that five or ten percent of incarcerated injectors were infected at incarceration. Hospitalisation rates for endocarditis remained static when we assumed that one percent of recently-incarcerated injectors were infected when incarcerated and increased during the first crackdown quarter when we assumed that five percent of these individuals were infected. In these multivariate models, precinct age and racial/ethnic composition, season, year, and borough remained statistically significant predictors of abscess and cellulitis hospitalisation rates; year and the percent of precinct residents who were non-Hispanic white remained significant predictors of endocarditis hospitalisation rates.

Table 3.

Multivariate regression of crackdown stages on precinct-specific hospitalisation rates for illicit-injection-related abscesses, cellulitis, and endocarditis among New York City's 27 crackdown precincts, 1995–1999: with and without adjustments for incarceration of individuals harbouring infectionsa

Crackdown stagesbHospitalisation rates for abscesses/cellulitisHospitalisation rates for endocarditis
No incarcerated individuals infected relative risk (95% confidence interval)5% of incarcerated individuals infected relative risk (95% confidence interval)10% of incarcerated individuals infected relative risk (95% confidence interval)No incarcerated individuals infected relative risk (95% confidence interval)1% of incarcerated individuals infected relative risk (95% confidence interval)5% of incarcerated individuals infected relative risk (95% confidence interval)
Baseline (referent)1.001.001.001.001.001.00
Preparation0.94 (0.85–1.04)0.95 (0.86–1.05)0.96 (0.87–1.05)1.21 (0.96–1.54)1.21 (0.97–1.51)1.19 (1.01–1.40)
Initiation month0.89 (0.78–1.00)0.91 (0.81–1.03)0.93 (0.83–1.05)0.96 (0.66–1.41)1.01 (0.72–1.42)1.11 (0.87–1.42)
First crackdown quarter0.88 (0.77–1.00)0.95 (0.83–1.08)1.01 (0.89–1.14)0.91 (0.66–1.25)1.02 (0.77–1.36)1.36 (1.10–1.69)*
Second crackdown quarter0.86 (0.74–0.99)*0.92 (0.79–1.06)0.97 (0.84–1.12)0.81 (0.62–1.06)0.92 (0.71–1.18)1.22 (0.99–1.50)
Third crackdown quarter0.80 (0.67–0.94)*0.85 (0.72–1.01)0.91 (0.77–1.07)0.74 (0.53–1.05)0.84 (0.62–1.15)1.13 (0.88–1.44)
Fourth crackdown quarter0.72 (0.57–0.91)*0.78 (0.62–0.97)*0.83 (0.67–1.03)0.57 (0.35–0.92)*0.68 (0.45–1.03)0.99 (0.73–1.35)
a

Adjusting for year, season, precinct borough, precinct racial/ethnic and age composition, and precinct poverty status.

b

Crackdown stage definitions: Baseline: 4–15 months prior to crackdown initiation; Preparation: 1–3 months prior to crackdown initiation; Initiation month: month of crackdown initiation; Crackdown quarters: quarters following each crackdown's initiation.

*

P<0.05.

Discussion 

return to Article Outline

Study results based on data for the non-institutionalised population in 27 crackdown precincts in NYC did not support our hypotheses that police drug crackdowns would be associated with increases in precinct-specific hospitalisation rates for illicit-injection-related abscesses, cellulitis, and endocarditis, and instead yielded evidence of a decline in these rates. Additional sensitivity analyses that took into account the likely infection rate among incarcerated individuals, however, suggested that hospitalisation rates remained largely static following the crackdowns’ initiation.

Our findings regarding the relationship of crackdown stage to hospitalisation rates are consonant with several possible scenarios. First, it is possible that the prevalence of injection drug use declined in the 27 crackdown precincts as a result of the crackdowns’ onset. The increase in drug-related arrests after each crackdown's initiation would have diminished the pool of injectors living in the precinct during the four quarters after each crackdown began. The magnitude of this reduction would have grown with each passing crackdown quarter as more injectors were arrested, repeat offenders were incarcerated for longer and longer periods, and injectors who did not use drugs while incarcerated continued to abstain from drugs after their release from the criminal justice system. This scenario is consistent with the increasing declines in hospitalisation rates seen in each subsequent crackdown quarter compared to baseline rates. While the sensitivity analyses allowed for the possibility that a proportion of recently-incarcerated individuals harboured the infections of interest, they did not account for the transfer of a substantial proportion of the at-risk population from the police precinct to the criminal justice system.

Additionally, research regarding drug treatment initiation suggests that entanglements with the criminal justice system are treatment motivators (Shutz, Rapiti, Vlahov, & Anthony, 1994; Weatherburn & Lind, 2001). While research by Wood and colleagues in Vancouver and Weatherburn and Lind in Sydney found no relationship between crackdowns and treatment admissions (Weatherburn & Lind, 1997; Wood et al., 2004), the latter investigation was hampered by a lack of variation in arrest rates and the former interviewed injectors only 3 months after the crackdown's onset. In contrast, the present study focused on crackdowns that generated a 39% increase in the median monthly drug-related arrest rate during the year following the eight crackdowns’ initiation and we followed precincts for 12 months after each crackdown's onset. Users’ resulting intensified involvement in the criminal justice system, or heightened concern about impending involvement, might have encouraged some to reduce the frequency with which they injected, switch to non-injection modes of administration, or abstain from drug use altogether.

A corollary scenario is also possible: while the crackdowns might have encouraged some injectors to stop or reduce their injection drug use, other individuals might have continued to inject drugs frequently and, in these heavily-policed circumstances, might have engaged in more unsafe injection practices during the crackdowns than prior to the crackdowns’ onset. Such a scenario would be consonant with the sensitivity analyses indicating a decline or stasis in hospitalisation rates for illicit-injection-related infections after the crackdowns began and also with all past research on fear of arrest and injection practices among active injectors (Aitken et al., 2002; Bluthenthal, Kral et al., 1999; Bluthenthal et al., 1997; Bluthenthal, Lorvick, et al., 1999; Bluthenthal & Watters, 1995; Bourgois, Lettiere, & Quesada, 1997; Cooper et al., in press; Grund, Heckathorn, & Anthony, 1995; Koester, 1994; Maher & Dixon, 1999; Zule, 1992). Given that our study contained no individual-level data with which to provide insight into individual drug use practices, however, we could not test this scenario's validity.

As Wood and colleagues, Curtis, and others have found, intensified drug-related policing activities can displace drug activity to new areas (Best, Strang, Beswick, & Gossop, 2001; Cooper et al., in press, Curtis, 2003, Wood et al., 2003, Wood et al., 2004). Three forms of displacement are possible, each of which may have exerted a different effect on rates of injection-related harms in crackdown precincts. First, injectors with access to private space may have shifted their drug use from parks and alleyways to private spaces within crackdown precincts to avoid police attention (Cooper et al., in press, Curtis, 2003). These injectors may have been better able to reduce the harm of their drug use in these private spaces than in public spaces, where access to running water and other materials needed for safe injection is limited or non-existent. Second, some crackdown residents may have started using drugs in non-crackdown precincts after the crackdown's onset, thus perhaps minimising their fear of arrest and consequent adverse health effects (Best et al., 2001, Curtis, 2003, Wood et al., 2003, Wood et al., 2004). It is also possible, however, that this displacement may have increased the likelihood of injecting outside (Wood et al., 2004), and thus increased the likelihood of unsafe injecting, as injectors began using drugs in unfamiliar neighbourhoods where they had few community ties. Finally, some injectors may have shifted not only the location in which they used drugs but also their residence from a crackdown to a non-crackdown precinct. Analyses of hospitalisation rates for illicit-injection-related infections in non-crackdown precincts adjacent to crackdown precincts, however, suggest that such displacement was insignificant.

Additionally, the estimated decline or stasis in hospitalisation rates after the crackdowns’ onset might partially be an artefact of the methods we used to identify cases of illicit-injection-related infections. Based on prior knowledge about typical sites of illicit-injection-related soft tissue infections (Ciccarone et al., 2001, Stone et al., 1990), our algorithm classified cases of abscess and cellulitis infection as illicit-injection-related if they occurred on the patient's extremities. It is possible, however, that drug-injecting residents might have endeavoured to avoid injecting in their extremities during the crackdown to minimise their visibility as drug users during a police search. A qualitative study exploring crackdowns and injection practices in one NYC crackdown precinct, conducted by the authors (Cooper et al., in press), suggests that some injectors employed this strategy to evade arrest. Similarly, we also used self-reported illicit drug use as a criterion for classifying infections as illicit-injection-related or not; it is possible that hospitalised individuals may have been more reluctant to disclose illicit drug use to health care personnel in the midst of the crackdown.

As stated earlier, we lacked access to HHC's inmate health data and thus used sensitivity analyses to investigate the effect on our analyses of excluding individuals who, had they not been incarcerated, would have remained eligible to be included in the SPARCS data for the non-institutionalised population. The elevated arrest rates found here following the crackdowns’ onset testify to the importance of taking the possible prison-based treatment of the infections of interest into account in the analyses, as does research suggesting that the quality of healthcare services provided within the criminal justice system may be similar or superior to that available in the community (Farley et al., 2000, White et al., 2001). Given the lack of actual data on infection rates among newly incarcerated individuals, however, our sensitivity analyses might have underestimated, or less plausibly, overestimated, the number of recently-incarcerated individuals harbouring the infections of interest.

Finally, unanticipated temporal trends in injection drug use, HIV/AIDS, and the incidence of hospitalisations for illicit-injection-related infections during the study period might have impeded our ability to detect crackdown-related changes in the outcomes. The number of injectors, and possibly those at particular risk of developing the outcomes, declined markedly citywide during the course of the study period. Research conducted by Friedman and colleagues and Holmberg suggests that the number of past-year injectors residing in the NYC metropolitan area declined by approximately 35% during the study period, from 197/10,000 residents in 1993 to 125/10,000 residents in 1998 (Friedman et al., 2004, Holmberg, 1993). Additionally, HIV incidence among injectors in NYC declined and highly active anti-retroviral therapy (HAART) emerged during the study period (Des Jarlais et al., 2000a, Des Jarlais et al., 2000b). Given that injectors with HIV, and perhaps in particular those with lower CD4 cell counts, are more susceptible to the infections studied than other injectors (Spijkerman, van Ameijden, Mientjes, Coutinho, & van den Hoek, 1997; Wilson, Thomas, Astemborski, Freedman, & Vlahov, 2002), these epidemiologic developments might have reduced the population at heightened risk of the study's outcomes during the study period. We were unable to incorporate these substantial reductions in the population at risk for illicit-injection-related infections in our statistical models; this limitation might have impaired our ability to compare trends in pre- and post-crackdown initiation hospitalisation rates, since we were analysing rates in relation to the total population in each precinct because no data exist on the size of the at-risk population (i.e., current injectors) in each precinct.

Similarly, the unanticipated citywide temporal increase in illicit-injection-related infections during the study period could have eclipsed any rise due solely to the crackdowns. This increase is of interest, particularly in a context of declining numbers of injection drug users in NYC. A contributing factor might be that injectors in NYC greatly increased their participation in syringe exchange programs during these years (Des Jarlais et al., 2000a, Des Jarlais et al., 2000b) and these programs may have linked injectors to hospital-based care for their infections. Research suggests that the rise in abscesses, cellulitis, and endocarditis found in NYC might not be a local phenomenon: a similar increase in hospitalisations for soft tissue infections occurred in San Francisco during the study period (Ciccarone et al., 2001). Similar to actions taken in San Francisco (Ciccarone et al., 2001), it may be useful in NYC for community clinicians, staff at programs serving injectors, epidemiologists, and active injectors to convene a task force to establish a research program to identify the causes of the increase in illicit-injection-related infections and formulate methods to address it. Given the morbidity and mortality associated with these infections, and the cost of treating them (charges for inpatient treatment of 945 individuals for soft tissue infections, the majority of which were injection-related, in one San Francisco hospital reached approximately (US) $9.9 million per fiscal year 1996–2000 (Ciccarone et al., 2001), such a task force should consider systematically monitoring patterns of hospitalisation for illicit-injection-related abscess, cellulitis, and endocarditis infections.

Study results suggest that further research into the effects of particular police strategies on injectors’ health is warranted. A useful line of inquiry lies in discerning which of the proposed scenarios described above, or which combination of these scenarios, is correct. Multi-level investigations examining the relationship between crackdowns and injectors’ health might be fruitful if they constructed the outcome as self-reported instances of illicit-injection-related infections and incorporated individual-level data regarding police encounters, injection drug use frequency and cessation, and injection practices and precinct-level data concerning the crackdown status of each participants’ home precinct and the precinct's sociodemographic profile. Additionally, as evidenced here by the elevated arrest rates following the crackdowns’ onset, future investigations should include information regarding inmate health status, acquired through processes that respect inmates’ human rights. Such research, coupled with past investigations into the relationship between arrest concerns and unsafe injection practices, could inform policy-makers entrusted with selecting drug-related law enforcement approaches about the possible unintended health consequences of the strategies under consideration.

Acknowledgments 

return to Article Outline

The authors would like to thank Ms. Sofia Gruskin and Dr. Lisa Moore for their contributions to the construction of the study and interpretation of the study's results. Additionally, we would like to thank Mr. Sidney Atwood for his generous assistance with data management and SAS; Ms. Bonnie Burns for her invaluable help with ArcView; Dr. Anne Kastor for helping to craft the algorithms to detect the infections of interest; and Dr. Ric Curtis for his insights into our findings.

This study was funded by a Robert Wood Johnson Substance Abuse Policy Research Program Grant (AOO589). During the final stages of manuscript preparation, the first author was supported by a Behavioral Sciences Training in Drug Abuse Research grant sponsored by the Medical and Health Research Association of New York City, Inc. and the National Development and Research Institutes, Inc. with funding from the National Institute on Drug Abuse (5T32 DA07233).

References 

return to Article Outline

Aitken et al., 2002. 1.Aitken C, Moore D, Higgs D, Kelsall J, Kerger M. The impact of a police crackdown on a street drug scene: Evidence from the street. The International Journal of Drug Policy. 2002;13:189–198.

Best et al., 2001. 2.Best D, Strang J, Beswick T, Gossop M. Assessment of a concentrated high-profile police operation: No discernable impact on drug availability, price, or purity. British Journal of Criminology. 2001;41:738–745.

Bluthenthal et al., 1999a. 3.Bluthenthal R, Kral A, Erringer E, Edlin B. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. Journal of Drug Issues. 1999;29(1):1–16.

Bluthenthal et al., 1997. 4.Bluthenthal R, Kral A, Lorvick J, Watters J. Impact of law enforcement on syringe exchange programs: A closer look at Oakland and San Francisco. Medical Anthropology. 1997;18:61–83.

Bluthenthal et al., 1999b. 5.Bluthenthal R, Lorvick J, Kral A, Erringer E, Kahn J. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. International Journal of Drug Policy. 1999;10:25–38.

Bluthenthal and Watters, 1995. 6.Bluthenthal, R., & Watters, J. (1995). Multi-method research: From targeted sampling to HIV risk behaviors. In Qualitative methods in the prevention of drug abuse and HIV research (Vol. 157, pp. 212–230). Rockville, MD: National Institute on Drug Abuse.

Bourgois et al., 1997. 7.Bourgois P, Lettiere M, Quesada J. Social misery and the sanctions of substance abuse: Confronting HIV risk among homeless heroin addicts in San Francisco. Social Problems. 1997;44(2):155–173.

Boyum and Kleiman, 1994. 8.Boyum, D., & Kleiman, M. (1994). Drug abuse control policy from a crime-control perspective (Vol. R94–16). Cambridge, MA: John F. Kennedy School of Government, Harvard University (Faculty Research Working Paper Series).

Chen and Kandel, 1995. 9.Chen K, Kandel D. The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health. 1995;85(1):41–47. MEDLINE | CrossRef

Ciccarone et al., 2001. 10.Ciccarone D, Bamberger J, Kral A, Edlin B, Hobart C, Moon A, et al. Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. Morbidity and Mortality Weekly. 2001;50(19):381–383.

Cooper et al., 2004. 11.Cooper H, Moore L, Gruskin S, Krieger N. Characterizing perceived police-related violence: Implications for public health. The American Journal of Public Health. 2004;94(7):1109–1118.

Cooper et al., in press. 12.Cooper, H., Moore, L., Gruskin, S., & Krieger, N. (in press). The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Social Science and Medicine.

Curtis, 2003. 13.Curtis R. Crack, cocaine, and heroin: Drug eras in Williamsburg, Brooklyn, 1960–2000. Addiction Research and Theory. 2003;11(1):47–63.

Des Jarlais et al., 1999. 14.Des Jarlais D, Friedman S, Perlis T, Chapman T, Sotheran J, Paone D, et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999;20:67–72. MEDLINE

Des Jarlais et al., 2000a. 15.Des Jarlais D, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, et al. HIV incidence among injection drug users in New York City, 1992–1997: Evidence for a declining epidemic. American Journal of Public Health. 2000;90(3):352–359. MEDLINE | CrossRef

Des Jarlais et al., 2000b. 16.Des Jarlais D, Perlis T, Friedman S, Chapman T, Kwok J, Rockwell R, et al. Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990–1997. American Journal of Public Health. 2000;90(7):1112–1116. MEDLINE | CrossRef

DeWitt and Paauw, 1996. 17.DeWitt D, Paauw D. Endocarditis infection in injection drug users. American Family Physician. 1996;53(6):2045–2049.

Diggle et al., 1994. 18.Diggle P, Liang K, Zegler S. The analysis of longitudinal data. New York: Oxford University Press; 1994;.

Farley et al., 2000. 19.Farley J, Mitty J, Mally M, Buzynski J, Tashima K, Rich J, et al. Comprehensive medical care among HIV-positive incarcerated women: The Rhode Island experience. Journal of Women's Health Care and Gender-Based Medicine. 2000;9(1):51–56.

Federal Bureau of Investigation, 2003. 20.Federal Bureau of Investigation. (2003). Crime in the United States, 2003; from http://www.ojp.usdoj.gov/bjs/dcf/tables/salespos.htm.

Fordyce et al., 1998. 21.Fordyce E, Shum R, Singh T, Forlenza S. Economic and geographic diversity in AIDS incidence among HIV exposure groups in New York City: 1983–1995. AIDS and Public Policy Journal. 1998;13(3):103–114. MEDLINE

Friedman et al., 1999. 22.Friedman S, Chapman T, Perlis T, Rockwell R, Paone D, Sotheran J, et al. Similarities and differences by race/ethnicity in changes in HIV seroprevalence and related behaviors among drug injectors in New York City, 1991–1996. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999;22(1):83–91.

Friedman et al., 2004. 23.Friedman SR, Tempalski B, Cooper H, Perlis T, Keem M, Friedman R, et al. Estimating numbers of IDUs in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for IDUs. The Journal of Urban Health. 2004;81(3):377–400.

Giuliani, 1997. 24.Giuliani, R. (1997). Removing drugs from our neighbourhoods and schools. Retrieved October 20, 1999; from http://www.ci.nyc.us/hymllom/html/nodrugs.html.

Greene, 1996. 25.Greene L. Policing places with drug problems. Thousand Oaks, CA: Sage Publications; 1996;.

Grund et al., 1995. 26.Grund J-P, Heckathorn D, Anthony D. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don’t carry syringes. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1995;10:105.

Haverkos et al., 1999. 27.Haverkos H, Turner F, Moolchan E, Cadet J-L. Relative rates of AIDS among racial/ethnic groups by exposure category. Journal of the National Medical Association. 1999;91(1):17–24. MEDLINE

Herb et al., 1989. 28.Herb, F., Watters, J., Case, P., & Petitti, D. (1989). Endocarditis, subcutaneous abscesses, and other bacterial infections in intravenous drug users and their association with skin-cleaning at drug injection sites. Paper presented at the 5th International Conference on AIDS, June 1989, Montreal, Canada, Abstract No. ThD04.

Holmberg, 1993. 29.Holmberg, S. (1993). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas: Supplementary material. Unpublished manuscript.

Joshi et al., 1999. 30.Joshi N, Caputo G, Weitecamp M, Karchner A. Infections in patients with diabetes mellitus. New England Journal of Medicine. 1999;341(25):1906–1912. MEDLINE | CrossRef

Kelling and Moore, 1985. 31.Kelling, G., & Moore, M. (1985). Observations on the police industry (Program on Criminal Justice Policy and Management No. 85-05-03). Cambridge, MA: John F. Kennedy School of Government, Harvard University (Working Paper, Program on Criminal Justice Policy and Management, 85-05-03).

Koester, 1994. 32.Koester S. Copping, running and paraphernalia laws: Contextual variables and needle risk behavior among injection drug users in Denver. Human Organization. 1994;53(3):287–295.

Krieger et al., 2001. 33.Krieger N, Waterman P, Lemieux K, Zierler S, Hogan J. On the wrong side of the tracts? Evaluating the accuracy of geocoding in public health research. American Journal of Public Health. 2001;91:1114–1116. MEDLINE | CrossRef

Maher and Dixon, 1999. 34.Maher L, Dixon D. Policing and public health: Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology. 1999;39(4):488–512.

Marzuk et al., 1997. 35.Marzuk P, Tardiff K, Leon A, Hirsch C, Stajic M, Portrera L, et al. Poverty and fatal overdoses of cocaine and opiates in New YorkCity: An ecological study. American Journal of Drug and Alcohol Abuse. 1997;23(2):221–228. MEDLINE | CrossRef

Moore, 1990. 36.Moore, M. (1990). An analytic view of drug control policies (Program in Criminal Justice Policy and Management No. 90-01-9). Cambridge, MA: John F. Kennedy School of Government, Harvard University (Working Paper, Program in Criminal Justice Policy and Management, 90-01-9).

Murasko and Bernstein, 1999. 37.Murasko D, Bernstein E. Immunology of aging. In:  Hazzard W,  Bless J,  Ettinger W,  Hattes J,  Ouslander J editor. Principles of geriatric medicine and gerontology. 4th ed.. New York: McGraw-Hill; 1999;p. 97–116.

Murphy et al., 2001. 38.Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft tissue abscess among injection drug users: A case–control study. Clinical Infectious Diseases. 2001;33(1):35–40. MEDLINE | CrossRef

National Institute of Justice, 1999. 39.National Institute of Justice. (1999). 1998 adult program findings. Retrieved August 2002, 2002; from http://www.adam.nij.net/adultfind.pdf.

New York Division of Criminal Justice Services, 2000. 40.New York Division of Criminal Justice Services . New York City arrest file codebook. Albany, NY: Bureau of Statistical Services, State of New York Division of Criminal Justice Services; 2000;.

Raveis and Kandel, 1987. 41.Raveis V, Kandel D. Changes in drug behavior from the middle to late twenties: Initiation, persistence, and cessation of use. American Journal of Public Health. 1987;77(5):607–611. MEDLINE | CrossRef

Rhodes, 2002. 42.Rhodes T. The “risk environment”: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy. 2002;13:85–94.

Rich et al., 1999. 43.Rich J, Strong L, Towe C, McKenzie M. Obstacles to needle exchange participation in Rhode Island. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999;21(5):396–400.

Schrager et al., 1991. 44.Schrager L, Friedlan G, Feinder C, Kahl P. Demographic characteristics, drug use and sexual behavior of iv drug users with AIDS In New York. Public Health Reports. 1991;106(1):78–84. MEDLINE

Shutz et al., 1994. 45.Shutz C, Rapiti E, Vlahov D, Anthony J. Suspected determinants of enrollment into detoxification and methadone treatment among injection drug users. Drug and Alcohol Dependence. 1994;36:129–138. MEDLINE | CrossRef

Spijkerman et al., 1997. 46.Spijkerman I, van Ameijden E, Mientjes G, Coutinho R, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. Journal of Clinical Epidemiology. 1997;49(10):1149–1154. Abstract | Full-Text PDF (623 KB) | CrossRef

Stone et al., 1990. 47.Stone M, Stone D, MacGregor H. Anatomical distribution of soft tissue infections in intravenous drug misusers attending an accident and emergency department. British Journal of Addiction. 1990;85:1495–1496. MEDLINE

Straumann et al., 1990. 48.Straumann E, Stulz P, Jenzer H. Tricuspid valve endocarditis in the drug addict: A reconstructive approach (‘vegetectomy’). Thoracic and Cardiovascular Surgeon. 1990;28:291–294. MEDLINE | CrossRef

U.S. Census Bureau, 1995. 49.U.S. Census Bureau. (1995). Statistical brief: Poverty areas. Retrieved May 20, 2004; from http://www.census.gov/population/socdemo/statbriefs/povarea.html.

U.S. Census Bureau, 2000. 50.U.S. Census Bureau. (2000). Census of population and housing 1991—Summary tape file 3: Technical documentation. Washington, DC: U.S. Department of Commerce, Economic and Statistics Administration, Bureau of the Census.

U.S. Census Bureau, 2003. 51.U.S. Census Bureau. (2003, 10/28/2003). Summary tape file 3: Technical documentation. Retrieved 4/27/2004, 2004; from http://www.census.gov/td/stf3/append_a.html.

Vlahov et al., 1992. 52.Vlahov D, Sullivan M, Astemborski J, Nelson K. Bacterial infections and skin cleaning prior to injecting among intravenous drug users. Public Health Reports. 1992;107(5):595–598. MEDLINE

Weatherburn and Lind, 1997. 53.Weatherburn D, Lind B. The impact of law enforcement activity on a heroin market. Addiction. 1997;92(5):557–569. MEDLINE | CrossRef

Weatherburn and Lind, 2001. 54.Weatherburn D, Lind B. Street-level drug law enforcement and entry into methadone maintenance treatment. Addiction. 2001;96(4):577–587. MEDLINE | CrossRef

White et al., 2001. 55.White M, Mehrotra A, Menendez E, Estes M, Goldenson J, Tulsky J. Jail inmates and HIV care: Provision of antiretroviral therapy and pnyeumocystis carinii pneumonia prophylaxis. International Journal of STD & AIDS. 2001;12:380–385. MEDLINE | CrossRef

Williams, 1990. 56.Williams H. Drug control strategies of united states law enforcement. Bulletin on Narcotics. 1990;42(1):27–39.

Wilson et al., 2002. 57.Wilson L, Thomas D, Astemborski J, Freedman TL, Vlahov D. Prospective study of infective endocarditis among injection drug users. Journal of Infectious Diseases. 2002;185(12):1761–1766. MEDLINE | CrossRef

Wood et al., 2003. 58.Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. The impact of a police presence on access to needle exchange programs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2003;34(1):116–118.

Wood et al., 2004. 59.Wood E, Spittal PM, Small W, Kerr T, Li K, Hogg RS, et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. Canadian Medical Association Journal. 2004;170(10):1551–1556. MEDLINE | CrossRef

Zule, 1992. 60.Zule W. Risk and reciprocity: HIV and the injection drug user. Journal of Psychoactive Drugs. 1992;24(3):243–249. MEDLINE

a Medical Health and Research Association of NYC, Inc./National Development and Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA

b Department of SocioMedicine Sciences, Columbia Mailman School of Public Health, 722 West 168th Street, 9th Floor, New York, 10032

c Clinical Research Program, Harvard Medical School, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA

d Department of Society, Human Development, and Health, Harvard School of Public Health, 677 Huntington Avenue, 7th Floor, Boston, MA 02115, USA

Corresponding Author InformationCorresponding author. Tel.: +1 212 845 4641; fax: +1 917 438 0894.

1 Tel.: +1 617 355 2641; fax: +1 617 355 2312.

2 Tel.: +1 617 432 1571; fax: +1 617 432 3123.

PII: S0955-3959(05)00046-0

doi:10.1016/j.drugpo.2005.03.001


View previous. 6 of 14 View next.